按組成部分、癌症類型、治療類型、最終用戶和地區分類的腫瘤學人工智慧 (AI) 的全球市場

Global Artificial Intelligence in Oncology Market, By Component, By Cancer Type, By Treatment Type, By End User, By Region

出版日期: 2023年12月26日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

腫瘤學領域人工智慧 (AI) 的全球市場規模預計將從 2023 年的 12 億美元增加到 2030 年的 91.642 億美元，預測期內複合年成長率為 33.7%。

報告範圍		報告詳情
基準年	2022年	2023/2024年市場規模	12億美元
實際資料	2018-2021	預測期	2023-2030
預測期間 2023/2024 至 2030/2031 年複合年成長率：	33.70%	2030/2031 年預測值	91.642 億美元

圖 1. 2023 年按地區分類的腫瘤學領域人工智慧 (AI) 的全球市場佔有率(%)

人工智慧（AI）在腫瘤學中發揮重要作用。有不同類型的人工智慧產品可以幫助癌症篩檢、診斷、治療和藥物開發。我們的主要產品之一是人工智慧輔助的癌症篩檢工具。這些工具使用在龐大的醫學影像資料庫上訓練的深度學習演算法。它可以幫助醫生檢測 CT、MRI 和乳房 X 光檢查等掃描影像中的異常情況。它可以快速分析大量圖像，並突出顯示醫生僅透過人工篩檢可能會錯過的可疑區域。這提高了早期腫瘤檢測的準確性並增加了挽救的生命數量。然而，隨著時間的推移改進演算法需要不斷更新新資料。還有誤診的風險，因為人工智慧可能無法有效區分罕見的癌症類型。

其他重要應用包括人工智慧在癌症診斷、預後和治療的應用。透過對大量基因組和臨床資料集進行機器學習，人工智慧可以識別複雜的模式，獲得新的見解，並比人類更好地預測治療反應。這有助於客製化標靶治療。人工智慧還透過幫助識別標靶、篩檢化合物和最佳化臨床試驗來加速藥物開發。

市場動態：

癌症發生率上升和癌症治療決策日益複雜是推動腫瘤學中採用人工智慧解決方案的關鍵因素。數位健康資料和運算能力的不斷增加正在推動先進人工智慧技術的發展。然而，開發高精度、臨床級人工智慧解決方案所需的高投資和成本是一個主要抑制因素。此外，缺乏對人工智慧所做決策的解釋和理解也限制了普及。另一方面，人工智慧透過實現個人化治療方法選擇來幫助克服抗藥性的潛力提供了機會。科技公司與研究機構的合作旨在進一步檢驗人工智慧的臨床應用潛力。

按地區分類，北美由於醫療費用高且獲得良好的醫療服務而佔據市場主導地位。然而，在中國和印度等國家的推動下，亞太地區是成長最快的市場。這種成長是由於經濟成長、可支配收入增加、醫療基礎設施擴大以及技術先進的癌症診斷工具的更多採用。

本研究的主要特點

本報告對全球腫瘤人工智慧（AI）市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和複合年成長率。
它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球腫瘤學市場人工智慧 (AI)的主要企業。
該報告的見解將使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
腫瘤學人工智慧 (AI) 全球市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球腫瘤學人工智慧 (AI) 市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023/2024:	US$ 1,200 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR:	33.70%	2030/2031 Value Projection:	US$ 9,164.2 Mn

Artificial intelligence (AI) plays an important role in oncology. There are various types of AI products that are helping in cancer screening, diagnosis, treatment, and drug development. One of the major products is an AI-assisted cancer screening tool. These tools use deep learning algorithms that have been trained on huge databases of medical images. They help physicians detect abnormalities in scans like CT, MRI, or mammograms. They can rapidly analyze a large number of images and highlight suspect areas that the doctor may miss with human screening alone. This improves the accuracy of detecting tumors at early stages and increases the number of lives saved. However, the algorithms need continuous updates with new data to improve over time. Misdiagnosis is also a risk because the AI may not be able to distinguish rare cancer types effectively.

Other important applications include the use of AI in cancer diagnostics, prognosis, and therapeutics. Using machine learning on vast pools of genomic and clinical cancer datasets, AI can recognize complex patterns, emerge with new insights, and predict treatment responses better than humans. This helps with customized and targeted therapy. AI is also speeding up drug development by assisting in target identification, compound screening, and clinical trial optimization.

Market Dynamics:

Rising cancer incidence coupled with the increasing complexity of cancer treatment decisions is a key factor driving the adoption of AI solutions in oncology. The growing availability of digital health data and computational power is facilitating the development of advanced AI technologies. However, the high investment and costs required for the development of precision and clinical-grade AI solutions are a major restraint. Lack of interpretability and understanding of how AI arrives at its decisions also limits widespread adoption. Meanwhile, the potential of AI to help overcome drug resistance by enabling personalized treatment selection presents an opportunity. Partnerships between technology companies and research institutes aim to further validate the clinical applicability of AI.

Among regions, North America dominates the market due to high healthcare expenditures and better access to care. However, Asia Pacific is poised to be the fastest-growing market arena, led by countries like China and India. This growth can be attributed to growing economies, rising disposable incomes, expanding medical infrastructure, and the increasing adoption of technologically advanced cancer diagnostic tools.

Key features of the study:

This report provides in-depth analysis of the global artificial intelligence in oncology market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global artificial intelligence in oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Azra AI, IBM Corporation, Siemens Healthineers AG, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI, Median Technologies, PathAI, Microsoft, Zebra Medical Vision, and Babylon
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global artificial intelligence in oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in oncology market

Global Artificial Intelligence in Oncology Market Segmentation:

By Component
- Software/Platform
- Hardware
- Services
By Cancer Type
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumor
- Others
By Treatment Type
- Chemotherapy
- Radiotherapy
- Immunotherapy
- Others
By End User:
- Hospitals & Clinics
- Diagnostic Centers
- Biopharmaceutical Companies
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Top companies in Global Artificial Intelligence in Oncology Market:
- Azra AI
- IBm Corporation
- Siemens Healthineers AG
- Intel Corporation
- GE HealthCare
- NVIDIA Corporation
- Digital Diagnostics Inc.
- ConcertAI
- Median Technologies
- PathAI
- Microsoft
- Zebra Medical Vision
- Babylon

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Top 3 Market Findings
- Top 3 Market Opportunity

3. Key Industry Insights

Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals/Launches
Company Market Share Analysis

4. Artificial Intelligence In Oncology Market, By Component Type, 2018 - 2030 ( US$ Million)

Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
- Segment Trends
Software Solutions, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Hardware, 2018 - 2030( US$ Million
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Services, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)

5. Artificial Intelligence In Oncology Market, By Cancer Type, 2018 - 2030 ( US$ Million)

Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
- Segment Trends
Breast Cancer, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Lung Cancer, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Prostate Cancer, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Colorectal Cancer, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Brain Tumor, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Others, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)

6. Artificial Intelligence In Oncology Market, By Treatment Type, 2018 - 2030 ( US$ Million)

Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
- Segment Trends
Chemotherapy, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Radiotherapy, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Immunotherapy, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Others, 2018 - 2030( US$ Million)
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)

7. Artificial Intelligence In Oncology Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2018 - 2030, ( US$ Million)
- Segment Trends
By Region
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
North America
- Introduction
- Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
U.S.
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Canada
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Europe
- Introduction
- Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
U.K
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Germany
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
France
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Italy
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Spain
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Russia
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Rest of Europe
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Asia Pacific
- Introduction
- Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
China
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
India
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Japan
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Australia
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
South Korea
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
ASEAN
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Rest of Asia Pacific
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Latin America
- Introduction
- Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
Brazil
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Mexico
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Argentina
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Rest of Latin America
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Middle East
- Introduction
- Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
GCC
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Israel
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Rest of Middle East
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Africa
- Introduction
- Market Size and Forecast, By Component Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2018 - 2030, ( US$ Million)
- Market Size and Forecast, By Country, 2018 - 2030, ( US$ Million)
North Africa
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
Central Africa
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)
South Africa
- Introduction
- Market Size and Forecast, 2018 - 2030, ( US$ Million)

8. Company Profiles - Artificial Intelligence In Oncology Market

NVIDIA Corporation*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Digital Diagnostics Inc.
ConcertAI
Median Technologies
PathAI
Azra AI
IBM
Siemens Healthcare GmbH